Tie-up with Summit Therapeutics boosted revenue
Russell Flannery is a senior editor and the Shanghai bureau chief at Forbes magazine. With a focus on business and finance in China, he covers a wide range of topics including technology, entrepreneurship, and market trends. Russell's articles provide insights into the Chinese market and its impact on global industries.